What is the clinical evidence from this study?

Study design: Cohort. Population: Coronary heart disease and frailty (n=1170). Intervention: AdaBoost machine learning prediction model vs. Other machine learning models (XGBoost, Random Forest, LightGBM, Logistic regression). Primary outcome: Area under the ROC curve (AUC) for predicting frailty risk in the validation group.

February 21, 2025Open Access

Construction and Verification of a Frailty Risk Prediction Model for Elderly Patients with Coronary Heart Disease Based on a Machine Learning Algorithm

Q: What does this research mean for the field?

An AdaBoost machine learning model incorporating ten clinical and demographic variables effectively predicts frailty risk in elderly patients with coronary heart disease, achieving an area under the ROC curve of 0.803. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Key Result

The AdaBoost machine learning model effectively predicted frailty risk in elderly patients with coronary heart disease, achieving an area under the ROC curve of 0.803 in the validation cohort.

Study Design

Type

Cohort (n=1,170)

Randomization

Randomly split into development and validation groups

Multicenter

Structured PICO

Can machine learning models accurately predict frailty risk in elderly patients with coronary heart disease?

Population

1,170 elderly patients (age ≥65 years) diagnosed with coronary heart disease from a tier-3 hospital in Anhui Province, China.

Intervention

Machine learning prediction models (AdaBoost, XGBoost, Random Forest, LightGBM, Logistic Regression) utilizing 10 clinical variables to predict frailty risk.

Outcome

Predictive accuracy for frailty risk, measured by Area Under the Receiver Operating Characteristic Curve (AUC).surrogate

Machine learning algorithms, particularly AdaBoost, can effectively predict frailty risk in elderly patients with coronary heart disease using routinely collected clinical variables.

Limitations

Data collection was limited to a single tertiary hospital, potentially limiting generalizability.
Use of data from a single institution could introduce selection bias.
Certain clinically relevant indicators or biomarkers significant for predicting frailty risk may have been inadvertently excluded.
The model has not yet been validated on independent external datasets.
Exertional chest pain, which disrupts daily activities and impacts quality of life, was not fully accounted for.
Risk of overfitting due to reliance primarily on machine learning techniques.

Abstract

Background: This study aimed to develop a machine learning-based predictive model for assessing frailty risk among elderly patients with coronary heart disease (CHD). Methods: From November 2020 to May 2023, a cohort of 1170 elderly patients diagnosed with CHD were enrolled from the Department of Cardiology of a tier-3 hospital in Anhui Province, China. Participants were randomly divided into a development group and a validation group, each containing 585 patients in a 1:1 ratio. Least absolute shrinkage and selection operator (LASSO) regression was employed in the development group to identify key variables influencing frailty among patients with CHD. These variables informed the creation of a machine learning prediction model, with the most accurate model selected. Predictive accuracy was subsequently evaluated in the validation group through receiver operating characteristic (ROC) curve analysis. Results: LASSO regression identified the activities of daily living (ADL) score, hemoglobin, low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), depression, cardiac function classification, cerebrovascular disease, diabetes, solitary living, and age as significant predictors of frailty among elderly patients with CHD in the development group. These variables were incorporated into a logistic regression model and four machine learning models: extreme gradient boosting (XGBoost), random forest (RF), light gradient boosting machine (LightGBM), and adaptive boosting (AdaBoost). AdaBoost demonstrated the highest accuracy in the development group, achieving an area under the ROC curve (AUC) of 0.803 in the validation group, indicating strong predictive capability. Conclusions: By leveraging key frailty determinants in elderly patients with CHD, the AdaBoost machine learning model developed in this study has shown robust predictive performance through validated indicators and offers a reliable tool for assessing frailty risk in this patient population.

AI से पूछें

Bookmark

View Full Paper